Sri Phani Krishna Karri

Sri Phani Krishna Karri

Active Director Director DIN 06792243
DIN 06792243 First appointment Feb 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Sri Phani Krishna Karri

Data last updated:

Sri Phani Krishna Karri is a Director at Skincurate Research Private Limited (since 2014). The company operates in Healthcare.

DIN 06792243
Primary Designation Director
Industry Healthcare
First Appointment 06 Feb 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skincurate Research Private Limited U85100WB2014PTC200016
Director06 Feb 20142014Active

Board colleagues of Sri Phani Krishna Karri

Directorship timeline

Open interactive timeline →
Skincurate Research Private Limited
Premium access

Shareholding and investment profile for Sri Phani Krishna Karri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Phani Krishna Karri

Sri Phani Krishna Karri currently holds 1 directorship: Skincurate Research Private Limited (Director, since 06 Feb 2014).

Sri Phani Krishna Karri was first appointed on 06 Feb 2014 as Director at Skincurate Research Private Limited.

The current boards of Sri Phani Krishna Karri's companies include Debdoot Sheet (Skincurate Research Private Limited), Kausik Basak (Skincurate Research Private Limited), Tamoghna Ojha (Skincurate Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available